InvestorsHub Logo
Followers 283
Posts 1162
Boards Moderated 0
Alias Born 10/04/2020

Re: None

Thursday, 06/03/2021 7:27:00 AM

Thursday, June 03, 2021 7:27:00 AM

Post# of 118366
Potential Merger Acquisition Between Precigen-RGBP?

Helen Sabzevari CEO of Preciden (PGEN) is on RGBP's scientific advisory board.

PGEN trades on Nasdaq with a Market Cap of $1.3 Billion and has an extensive clinical trials pipeline in Immunology-Oncology that includes development of mRNA vaccines and therapies.

Precigen.com

https://precigen.com/about/

Food for thought only.

Be well and prosper...